Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Compass BDS Biliary Stent

K-Number: K213946 · 2022-05-09

Decision Date2022-05-09
Product CodeFGE
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Compass BDS Biliary Stent is a medical device manufactured by Cook Ireland, Ltd.. It received FDA 510(k) clearance on 2022-05-09 under approval number K213946. The device is classified under product code FGE. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Compass BDS Biliary Stent?

Compass BDS Biliary Stent is a medical device that received FDA 510(k) clearance on 2022-05-09. It is manufactured by Cook Ireland, Ltd.. The 510(k) number is K213946.

When was Compass BDS Biliary Stent approved by the FDA?

Compass BDS Biliary Stent received FDA 510(k) clearance on 2022-05-09, under approval number K213946.

What company makes Compass BDS Biliary Stent?

Compass BDS Biliary Stent is manufactured by Cook Ireland, Ltd..

What is the FDA product code for Compass BDS Biliary Stent?

The FDA product code for Compass BDS Biliary Stent is FGE.

Related Clinical Trials

Other Devices by Cook Ireland, Ltd.

View all 19 devices →

Related Devices (Code: FGE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.